|Cancer biomarkers-current perspectives|
AN Bhatt, R Mathur, A Farooque, A Verma, BS Dwarakanath
Indian J Med Res 132 (2), 129-149, 2010
|Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway|
R Mathur*, G Wan*, X Hu, Y Liu, X Zhang, G Peng, X Lu
Cellular signalling 25 (5), 1086-1095, 2013
|miRNA response to DNA damage|
G Wan, R Mathur, X Hu, X Zhang, X Lu
Trends in biochemical sciences 36 (9), 478-484, 2011
|miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase|
Y Zhou, G Wan, R Spizzo, C Ivan, R Mathur, X Hu, X Ye, J Lu, F Fan, L Xia, ...
Molecular oncology 8 (1), 83-92, 2014
|FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma|
L Sehgal, R Mathur, FK Braun, JF Wise, Z Berkova, S Neelapu, LW Kwak, ...
Leukemia 28 (12), 2376-2387, 2014
|Low-dose radiation therapy of cancer: role of immune enhancement|
A Farooque*, R Mathur*, A Verma, V Kaul, AN Bhatt, JS Adhikari, F Afrin, ...
Expert review of anticancer therapy 11 (5), 791-802, 2011
|LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2|
X Wang, L Sehgal, N Jain, T Khashab, R Mathur, F Samaniego
Journal of translational medicine 14 (1), 1-14, 2016
|Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex|
JF Wise, Z Berkova, R Mathur, H Zhu, FK Braun, RH Tao, AL Sabichi, ...
Blood, The Journal of the American Society of Hematology 121 (23), 4729-4739, 2013
|The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in Ehrlich ascites tumor bearing mice|
S Gupta, R Mathur, B Dwarakanath
Cancer biology & therapy 4 (1), 94-101, 2005
|Targeting Wnt pathway in mantle cell lymphoma-initiating cells|
R Mathur, L Sehgal, FK Braun, Z Berkova, J Romaguerra, M Wang, ...
Journal of hematology & oncology 8 (1), 1-12, 2015
|Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs|
R Mathur, L Sehgal, O Havranek, S Köhrer, T Khashab, N Jain, JA Burger, ...
Haematologica 102 (2), 373, 2017
|HuR suppresses Fas expression and correlates with patient outcome in liver cancer|
H Zhu, Z Berkova, R Mathur, L Sehgal, T Khashab, RH Tao, X Ao, L Feng, ...
Molecular Cancer Research 13 (5), 809-818, 2015
|Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells|
P Fan, AK Tyagi, FA Agboke, R Mathur, N Pokharel, VC Jordan
Cell death discovery 4 (1), 1-14, 2018
|A novel BCMA-specific, centyrin-based CAR-T product for the treatment of multiple myeloma|
DL Hermanson, BE Barnett, S Rengarajan, R Codde, X Wang, Y Tan, ...
Blood, The Journal of the American Society of Hematology 128 (22), 2127-2127, 2016
|Inhibitors of topoisomerases as anticancer drugs: problems and prospects|
BS Dwarakanath, D Khaitan, R Mathur
NISCAIR-CSIR, India, 2004
|Universal SLAMF7-specific CAR T-cells as treatment for multiple myeloma|
R Mathur, Z Zhang, J He, R Galetto, A Gouble, I Chion-Sotinel, S Filipe, ...
Blood 130 (Supplement 1), 502-502, 2017
|Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis|
FK Braun, R Mathur, L Sehgal, R Wilkie-Grantham, J Chandra, Z Berkova, ...
PloS one 10 (3), e0117994, 2015
|90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease|
F Samaniego, Z Berkova, JE Romaguera, N Fowler, MA Fanale, B Pro, ...
British journal of haematology 167 (2), 207-213, 2014
|T-regulatory cells in tumor progression and therapy|
A Verma, R Mathur, A Farooque, V Kaul, S Gupta, BS Dwarakanath
Cancer management and research 11, 10731, 2019
|Targeting nucleolin for better survival in diffuse large B-cell lymphoma|
N Jain, H Zhu, T Khashab, Q Ye, B George, R Mathur, RK Singh, ...
Leukemia 32 (3), 663-674, 2018